{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:00:19Z","timestamp":1790402419816,"version":"4.1.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":594,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dis Esophagus"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1111\/dote.12165","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T03:23:40Z","timestamp":1389842620000},"page":"196-203","source":"Crossref","is-referenced-by-count":57,"title":["Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma"],"prefix":"10.1093","volume":"28","author":[{"given":"Y.-F.","family":"Zhang","sequence":"first","affiliation":[{"name":"Institute of Oncologic Pathology; Shantou University Medical College; Shantou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.-X.","family":"Xu","sequence":"additional","affiliation":[{"name":"Institute of Oncologic Pathology; Shantou University Medical College; Shantou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.-D.","family":"Liao","sequence":"additional","affiliation":[{"name":"Institute of Oncologic Pathology; Shantou University Medical College; Shantou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.-E.","family":"Xu","sequence":"additional","affiliation":[{"name":"Institute of Oncologic Pathology; Shantou University Medical College; Shantou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area; Shantou University Medical College; Shantou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.-Y.","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology Surgery; Shantou Central Hospital, Affiliated Shantou Hospital of Sun Yat-Sen University; Shantou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-H.","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pathology; Shantou Central Hospital, Affiliated Shantou Hospital of Sun Yat-Sen University; Shantou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.-M.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area; Shantou University Medical College; Shantou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.-Y.","family":"Xu","sequence":"additional","affiliation":[{"name":"Institute of Oncologic Pathology; Shantou University Medical College; Shantou China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,15]]},"reference":[{"key":"10.1111\/dote.12165-BIB0001|dote12165-cit-0001","doi-asserted-by":"crossref","first-page":"L461","DOI":"10.1016\/0024-3205(94)00533-8","article-title":"Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs","volume":"55","author":"Zadina","year":"1994","journal-title":"Life Sci"},{"key":"10.1111\/dote.12165-BIB0002|dote12165-cit-0002","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.36076\/ppj.2008\/11\/S133","article-title":"Opioid pharmacology","volume":"11","author":"Trescot","year":"2008","journal-title":"Pain Physician"},{"key":"10.1111\/dote.12165-BIB0003|dote12165-cit-0003","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nrn1914","article-title":"Cancer pain and its impact on diagnosis, survival and quality of life","volume":"7","author":"Mantyh","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1111\/dote.12165-BIB0004|dote12165-cit-0004","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/1097-0282(2000)55:4<334::AID-BIP1006>3.0.CO;2-S","article-title":"Structure and regulation of opioid receptors","volume":"55","author":"Chaturvedi","year":"2000","journal-title":"Biopolymers"},{"key":"10.1111\/dote.12165-BIB0005|dote12165-cit-0005","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.conb.2007.10.004","article-title":"The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence","volume":"17","author":"Martini","year":"2007","journal-title":"Curr Opin Neurobiol"},{"key":"10.1111\/dote.12165-BIB0006|dote12165-cit-0006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1744-8069-7-9","article-title":"Identification and characterization of seven new exon 11-associated splice variants of the rat mu opioid receptor gene, OPRM1","volume":"7","author":"Xu","year":"2011","journal-title":"Mol Pain"},{"key":"10.1111\/dote.12165-BIB0007|dote12165-cit-0007","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2217\/pgs.11.68","article-title":"Pharmacogenomics of the human micro-opioid receptor","volume":"12","author":"Kasai","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1111\/dote.12165-BIB0008|dote12165-cit-0008","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.2741\/1471","article-title":"Endogenous morphinergic signaling and tumor growth","volume":"9","author":"Cadet","year":"2004","journal-title":"Front Biosci"},{"key":"10.1111\/dote.12165-BIB0009|dote12165-cit-0009","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/B:CANC.0000031773.46458.63","article-title":"Opioid peptides in cancer","volume":"23","author":"Fichna","year":"2004","journal-title":"Cancer Metastasis Rev"},{"key":"10.1111\/dote.12165-BIB0010|dote12165-cit-0010","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1213\/ANE.0b013e31820568af","article-title":"The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation","volume":"112","author":"Mathew","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1111\/dote.12165-BIB0011|dote12165-cit-0011","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/ALN.0b013e31824babe2","article-title":"Overexpression of the mu-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis","volume":"116","author":"Lennon","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1111\/dote.12165-BIB0012|dote12165-cit-0012","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-011-9285-0","article-title":"Morphine and tumor growth and metastasis","volume":"30","author":"Afsharimani","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"10.1111\/dote.12165-BIB0013|dote12165-cit-0013","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1213\/ANE.0b013e3181d8d183","article-title":"Surgery for cancer: does anesthesia matter?","volume":"110","author":"Bovill","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1111\/dote.12165-BIB0014|dote12165-cit-0014","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/ALN.0b013e31824b9512","article-title":"The mu-opioid receptor in cancer progression: is there a direct effect?","volume":"116","author":"Lennon","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1111\/dote.12165-BIB0015|dote12165-cit-0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1111\/dote.12165-BIB0016|dote12165-cit-0016","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.humpath.2012.11.025","article-title":"Kappa-opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma","volume":"44","author":"Zhang","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1111\/dote.12165-BIB0017|dote12165-cit-0017","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C","article-title":"Characterization of 21 newly established esophageal cancer cell lines","volume":"69","author":"Shimada","year":"1992","journal-title":"Cancer"},{"key":"10.1111\/dote.12165-BIB0018|dote12165-cit-0018","first-page":"357","article-title":"Establishment of an epithelial cell line from human esophageal carcinoma","volume":"2","author":"Cancer Institute of the Chinese Academy of Medical Sciences (CICAMS)","year":"1976","journal-title":"Chin Med J"},{"key":"10.1111\/dote.12165-BIB0019|dote12165-cit-0019","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1369\/jhc.7A7353.2007","article-title":"Fascin expression in human embryonic, fetal, and normal adult tissue","volume":"56","author":"Zhang","year":"2008","journal-title":"J Histochem Cytochem"},{"key":"10.1111\/dote.12165-BIB0020|dote12165-cit-0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1139\/O08-001","article-title":"Opioid-induced regulation of mu-opioid receptor gene expression in the MCF-7 breast cancer cell line","volume":"86","author":"Gach","year":"2008","journal-title":"Biochem Cell Biol"},{"key":"10.1111\/dote.12165-BIB0021|dote12165-cit-0021","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1002\/cncr.28345","article-title":"Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer","volume":"119","author":"Zylla","year":"2013","journal-title":"Cancer"},{"key":"10.1111\/dote.12165-BIB0022|dote12165-cit-0022","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3892\/or.2013.2640","article-title":"In vivo and in vitro inhibition of human liver cancer progress by downregulation of the mu-opioid receptor and relevant mechanisms","volume":"30","author":"Lu","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1111\/dote.12165-BIB0023|dote12165-cit-0023","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10620-007-9897-y","article-title":"Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon","volume":"53","author":"Nylund","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1111\/dote.12165-BIB0024|dote12165-cit-0024","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2478\/s11535-010-0097-y","article-title":"Opioid-receptor gene expression and localization in cancer cells","volume":"6","author":"Gach","year":"2011","journal-title":"Cent Eur J Biol"},{"key":"10.1111\/dote.12165-BIB0025|dote12165-cit-0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/path.4236","article-title":"Down-regulated desmocollin-2 promotes cell aggressiveness through redistributing adherens junctions and activating beta-catenin signalling in oesophageal squamous cell carcinoma","volume":"231","author":"Fang","year":"2013","journal-title":"J Pathol"},{"key":"10.1111\/dote.12165-BIB0026|dote12165-cit-0026","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2174\/092986708783955518","article-title":"The other side of the opioid story: modulation of cell growth and survival signaling","volume":"15","author":"Chen","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1111\/dote.12165-BIB0027|dote12165-cit-0027","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0306-4522(03)00135-0","article-title":"Ligand-induced mu opioid receptor endocytosis and recycling in enteric neurons","volume":"119","author":"Minnis","year":"2003","journal-title":"Neuroscience"},{"key":"10.1111\/dote.12165-BIB0028|dote12165-cit-0028","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0002-9440(10)64761-X","article-title":"Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma","volume":"156","author":"Shiomi","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1111\/dote.12165-BIB0029|dote12165-cit-0029","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1747-0285.2009.00875.x","article-title":"The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell line","volume":"74","author":"Gach","year":"2009","journal-title":"Chem Biol Drug Des"},{"key":"10.1111\/dote.12165-BIB0030|dote12165-cit-0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1139\/y05-127","article-title":"G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm","volume":"84","author":"Gobeil","year":"2006","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1111\/dote.12165-BIB0031|dote12165-cit-0031","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0301-0082(02)00008-4","article-title":"Exploring the opioid system by gene knockout","volume":"66","author":"Kieffer","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1111\/dote.12165-BIB0032|dote12165-cit-0032","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3727\/036012909803861095","article-title":"Substance P and beta endorphin mediate electroacupuncture induced analgesic activity in mouse cancer pain model","volume":"34","author":"Lee","year":"2009","journal-title":"Acupunct Electrother Res"},{"key":"10.1111\/dote.12165-BIB0033|dote12165-cit-0033","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/ALN.0b013e31824b96a1","article-title":"\u03bc-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer","volume":"116","author":"Bortsov","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1111\/dote.12165-BIB0034|dote12165-cit-0034","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0625.2010.01158.x","article-title":"Endogenous-opioid peptides modulate immune response towards malignant melanoma","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1111\/dote.12165-BIB0035|dote12165-cit-0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejphar.2007.10.015","article-title":"Endogenou opioid peptides, endomorphin-1 and -2 and deltorphin I stimulate angiogenesis in the CAM assay","volume":"579","author":"Dai","year":"2008","journal-title":"Eur J Pharmaco"},{"key":"10.1111\/dote.12165-BIB0036|dote12165-cit-0036","first-page":"4491","article-title":"Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth","volume":"62","author":"Gupta","year":"2002","journal-title":"Cancer Res"},{"key":"10.1111\/dote.12165-BIB0037|dote12165-cit-0037","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2009.11.035","article-title":"The stimulative effects of endogenous opioids on endothelial cell proliferation, migration and angiogenesis in vitro","volume":"628","author":"Dai","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/dote.12165-BIB0038|dote12165-cit-0038","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1158\/1535-7163.MCT-05-0016","article-title":"Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells","volume":"5","author":"Farooqui","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/dote.12165-BIB0039|dote12165-cit-0039","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mvr.2006.04.004","article-title":"Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation","volume":"72","author":"Singleton","year":"2006","journal-title":"Microvasc Res"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdote.12165","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/dote\/article-pdf\/28\/2\/196\/10398191\/dote0196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:32:05Z","timestamp":1648063925000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article-lookup\/doi\/10.1111\/dote.12165"}},"subtitle":["MOR1 in esophageal squamous cell carcinoma"],"short-title":[],"issued":{"date-parts":[[2014,1,15]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"URL":"https:\/\/doi.org\/10.1111\/dote.12165","relation":{},"ISSN":["1120-8694"],"issn-type":[{"value":"1120-8694","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,15]]}}}